Statistics
Publications
2
Citations
199
H-Index
2
Active since
2003
Affiliations
Chris Rusconi is an author at Pharmaceutical Product Development (United States) specializing in medicine, oncology, and immune checkpoint regulation.
Publications per year
2003–2024
2
2
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
Sandra Santulli-Marotto, Smita K. Nair, Chris Rusconi et al. · PubMed · 2003 · 189 citations
Medicine, Immunology, Oncology +17
1–2 of 2